Making PrEP accessible: Updates on long-acting injectable options

Dr. Arrington-Sanders is an Associate Professor of adolescent medicine, pediatrics and internal medicine at Johns Hopkins University. She is a member of the International AIDS Society Governing Council. She has a joint appointment in the Division of Infectious Diseases at the Johns Hopkins School of Medicine and Johns Hopkins Bloomberg School of Public Health’s Departments of Epidemiology and Health, Behavior and Society. She serves as Medical Director of the Pediatric and Adolescent HIV/AIDS Program, Director of the PrEP Program (prepisforyouth.org) in the Harriet Lane Clinic at Johns Hopkins Children’s Center, and co-Director of the Adolescent and Young Adult Scientific Working Group at Johns Hopkins Center for AIDS Research.  Her expertise includes developing intersectional culturally congruent youth-centered approaches to address the needs of sexual and gender diverse youth who are living with and at-risk for HIV. 

Beatriz Grinsztejn is the IAS President-Elect, and is an infectious disease physician-researcher who has dedicated her career to HIV and AIDS care and research. With colleagues, she established the FIOCRUZ HIV/AIDS Service, which is the largest care provider and houses the first established trans health clinic in Rio de Janeiro, Brazil. She is the Director of the HIV Clinical Trials Unit at FIOCRUZ in Rio de Janeiro.

Beatriz has contributed to advancing the science on HIV prevention and treatment and has led or participated seminal global HIV research studies, being currently the Co-Chair of the HPTN 083 study to evaluate injectable cabotegravir for PrEP in HIV-negative men who have sex with men and trans women.

Sunil Suhas Solomon is a Professor of Medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. He completed his medical training in India and received a Masters in Public Health and a doctorate in Epidemiology (PhD) from the Johns Hopkins University, USA. Dr. Solomon has been elected into the Phi Beta Kappa and the Delta Omega honors societies. His research is primarily focused on the epidemiology, prevention, clinical management and access to care for HIV, viral hepatitis and other infectious diseases among vulnerable populations including people who inject drugs and men who sex with men.

Shakirah Namwanje is the Policy Research and Advocacy Officer at the Uganda Network of AIDS Service Organizations UNASO with over six years of HIV and SRHR Advocacy Specializing in HIV Prevention and Research Advocacy, Advocacy for Cure Research and SRHR with emphasis on Young people. Shakirah uses that experience coupled with Music Dance and Drama to educate and engage Young people and key stakeholders. She is the recently awarded HIV/LEADER of the year 2022 by the Ministry of Health Uganda.

Mitchell Warren has spent nearly 30 years devoted to expanding access to HIV prevention. He says he has had the great fortune to work with a wide range of activists and advocates, researchers and scientists, product developers and deliverers, policy makers, community advisory boards and the media from across the globe.

Since 2004, Mitchell has been the Executive Director of AVAC, an international non-governmental organization that works to accelerate the ethical development and global delivery of HIV prevention options as part of a comprehensive and integrated pathway to global health equity.

He is currently the Co-Chair of the Global HIV Prevention Coalition, a member of the PEPFAR Scientific Advisory Board, and President of the TB Alliance Stakeholder Association. He is also a member of the IAS Governing Council.